CollaRx gentamicin topical: Preliminary Phase II data

Preliminary data from a double-blind, placebo-controlled Phase II trial in 49 patients showed that CollaRx produced an infection rate of 6% vs. 36% for placebo. Patients received placebo or one CollaR...